Developing failure criteria for laceration injury of dermal tissue.

Despite its importance, there is a poor understanding of human injury tolerance to trauma generally, and more specifically understanding of the mechanics of skin penetration or laceration. The objective of this analysis is to determine the failure criteria that will allow the evaluation of the laceration risk of blunt-tipped edges within a computational modeling environment. An axisymmetric tissue finite element model was set up in Abaqus 2021 to match the experimental set-up from a previous study. The model simulated the pressing of penetrometer geometries into dermal tissue, and stress and strain outputs were evaluated at the experimental failure force. Two separate nonlinear hyperelastic material models were calibrated for the dermis to data from the literature (high and low stiffness models). For both the high-stiffness and low-stiffness skin models, the failure force appears to occur near a local maximum in the principal strain. All failures occurred after the maximum strain near or at the top surface is or above 59%, with mid-thickness strain at a similar level. The strain energy density is concentrated near the edge tip for each configuration, indicating highly localized material damage at the point of loading, and increases rapidly prior to the approximate failure force. As the edge is further compressed into the tissue, the stress triaxiality near the edge contacting point decreases towards zero. This study has identified general failure criteria for skin laceration which can be implemented in a computational model. A higher risk for laceration would be indicated with strain energy density larger than 60 mJ/mm3 , dermal strain larger than 55%, and stress triaxiality below 0.1. These findings were largely insensitive to the dermal stiffness and broadly applicable across different indenter geometries. It is expected that this framework may be implemented to evaluate hazardous forces for product edges, interactions with robots, and interfaces with medical and drug delivery devices.